BMJ announced an extended partnership with Bibliosan to provide 65 institutions across Italy with full access to the Comorbidities tool from BMJ Best Practice and BMJ Case reports. Under the deal, Bibliosan members will now gain can now have access to Comorbidities from BMJ Best Practice. The Comorbidities tool claims to be the only point of care tool that supports the management of the whole patient. Additionally, members will also gain full access to BMJ Case Reports content, enabling them to publish unlimited cases.
Comorbidities are a significant problem in Italy. About one-fifth of Italians are affected by significant multi-morbidity conditions. This puts an increasing demand on healthcare systems and clinical teams who need to recognise a patient’s comorbidities - and understand how they might change the treatment approach.
Launched in September 2020, the Comorbidities tool from BMJ Best Practice is a point of care tool that supports the management of the whole patient by including guidance on the treatment of a patient’s acute condition alongside their pre-existing comorbidities. Access to the dedicated Comorbidities tool in BMJ Best Practice will help healthcare professionals in Bibliosan’s research institutions avoid unnecessary treatments, improve patient outcomes, and reduce costs.
With over 20,000 case reports, BMJ Case Reports is the largest database of clinical case reports and an educational resource for healthcare professionals and researchers who need to easily find clinically important information on common and rare conditions. All articles are peer-reviewed and copy edited before publication.
Under the new agreement, Bibliosan guarantees unrestrained access and unrestricted publication to all syndicated biomedical institutions.
Click here to read the original press release.
